Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis
Journal article
Brown AC. et al, (2023), Cell Genomics, 3, 100306 - 100306
Chromosome conformation capture approaches to investigate 3D genome architecture in Ankylosing Spondylitis
Journal article
Davidson C. et al, (2023), Frontiers in Genetics, 14
Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the RUNX3 Promoter
Journal article
Cohen CJ. et al, (2022), Frontiers in Genetics, 12
FUNCTIONAL GENOMICS INVESTIGATION OF THE ANKYLOSING SPONDYLITIS ASSOCIATED LOCUS RUNX3
Conference paper
Cohen C. et al, (2022), ANNALS OF THE RHEUMATIC DISEASES, 81, 231 - 231
INVESTIGATING THE ANKYLOSING SPONDYLITIS-ASSOCIATED REGULATORY SNPS AT THE RUNX3 LOCUS WITH A FUNCTIONAL GENOMICS APPROACH
Conference paper
Vecellio M. et al, (2021), ANNALS OF THE RHEUMATIC DISEASES, 80, 411 - 411
Perspectives on the Genetic Associations of Ankylosing Spondylitis
Journal article
Wordsworth BP. et al, (2021), Frontiers in Immunology, 12
COMPREHENSIVE EPIGENOMIC PROFILING REVEALS DISEASE-SPECIFIC CHROMATIN STATES IN ANKYLOSING SPONDYLITIS
Conference paper
Cohen CJ. et al, (2021), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 39, 1155 - 1155
Functional Genomic Analysis of a RUNX3 Polymorphism Associated with Ankylosing Spondylitis
Journal article
Vecellio M. et al, (2020), Arthritis & Rheumatology
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
Journal article
Watts L. et al, (2019), Genes & Immunity, 20, 167 - 171
Quantifying the genetic risk for the development of axial spondyloarthropathy
Journal article
Wordsworth BP. et al, (2018), Current Opinion in Rheumatology, 30, 319 - 323
INVESTIGATING THE REGULATORY SNPS AT THE RUNX3 LOCUS ASSOCIATED WITH ANKYLOSING SPONDYLITIS
Conference paper
Vecellio ML. et al, (2018), ANNALS OF THE RHEUMATIC DISEASES, 77, 158 - 158
Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism
Journal article
Vecellio M. et al, (2018), RMD Open, 4, e000628 - e000628
EXPLORING THE ANKYLOSING SPONDYLITIS-ASSOCIATED REGULATORY SNPs AT THE RUNX3 LOCUS
Conference paper
Vecellio M. et al, (2018), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 36, 734 - 734
RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis-Novel Targets for Therapy?
Journal article
Vecellio M. et al, (2018), Frontiers in immunology, 9
Investigation of a possible extended risk haplotype in the IL23R region associated with ankylosing spondylitis
Journal article
Roberts AR. et al, (2017), Genes & Immunity, 18, 105 - 108
An ankylosing spondylitis-associated genetic variant in theIL23R-IL12RB2intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation
Journal article
Roberts AR. et al, (2016), Annals of the Rheumatic Diseases, 75, 2150 - 2156
The genetic association ofRUNX3with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression
Journal article
Vecellio M. et al, (2016), Annals of the Rheumatic Diseases, 75, 1534 - 1540
THE ASSOCIATION OF A COMMON FUNCTIONAL POLYMORPHISM IN THE TUMOUR NECROSIS FACTOR RECEPTOR 1 GENE (TNFRSF1A) AND DISEASE SEVERITY IN ANKYLOSING SPONDYLITIS
Conference paper
Watts L. et al, (2016), RHEUMATOLOGY, 55, 150 - 150
A CCR6 variant strongly associated with rheumatoid arthritis in two populations is not associated with ankylosing spondylitis
Journal article
Cohen CJ. et al, (2013), Rheumatology International, 33, 2443 - 2444